These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6636150)

  • 1. Characteristics of phospholipids associated with fibrins in partial thromboplastin test.
    Ogawa S; Kurokawa I; Akino T
    Tohoku J Exp Med; 1983 Sep; 141(1):61-9. PubMed ID: 6636150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preparation of a sensitive partial thromboplastin reagent from bovine brain.
    Martin BA; Branch DW; Rodgers GM
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):287-94. PubMed ID: 1643206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet lipids and coagulation in plasma. II. Thromboplastic activity.
    Boggust WA
    Ir J Med Sci; 1972; 141(10):168-80. PubMed ID: 4568956
    [No Abstract]   [Full Text] [Related]  

  • 4. APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N
    J Thromb Haemost; 2012 Nov; 10(11):2338-43. PubMed ID: 22909048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodical aspects of blood coagulation measurements in birds applying commercial reagents--a pilot study.
    Guddorf V; Kummerfeld N; Mischke R
    Berl Munch Tierarztl Wochenschr; 2014; 127(7-8):322-7. PubMed ID: 25080826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of phospholipid reagents used in coagulation II: factors influencing their sensitivity to heparin.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):634-7. PubMed ID: 7314057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythrophosphatide: a reagent for coagulation studies].
    Rakitianskaia AA; Khomich EN; Gilevskiĭ EN
    Lab Delo; 1982; (1):32-4. PubMed ID: 6174785
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference.
    Okuda M; Yamamoto Y
    Clin Lab Haematol; 2004 Jun; 26(3):215-23. PubMed ID: 15163321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Test for detection of activated partial thromboplastin time using ellagic acid].
    Berkovskiĭ AL; Sergeeva EV; Kachalova ND; Prostakova TM; Kozlov AA
    Klin Lab Diagn; 1999 Jun; (6):18-20. PubMed ID: 10459199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new Russian phospholipid reagent from soybeans for the study of activated partial thromboplastin time].
    Staritsyna NN; Shanskaia AI; Khrolova PV; Papaian LP
    Klin Lab Diagn; 1993; (6):43-5. PubMed ID: 8032782
    [No Abstract]   [Full Text] [Related]  

  • 12. Contact activation: important to consider when measuring the contribution of tissue factor-bearing microparticles to thrombin generation using phospholipid-containing reagents.
    Boknäs N; Faxälv L; Lindahl TL; Ramström S
    J Thromb Haemost; 2014 Apr; 12(4):515-8. PubMed ID: 24405583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies.
    Turi DC; Peerschke EI
    Am J Clin Pathol; 1986 Jan; 85(1):43-9. PubMed ID: 3940420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis on characteristics of two activated partial thromboplastin time reagents.
    Yasui Y; Ishii T; Tatebe J; Morita T
    J Clin Lab Anal; 2022 Sep; 36(9):e24608. PubMed ID: 35853032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation among commercial activated partial thromboplastin time reagents in response to heparin.
    Shapiro GA; Huntzinger SW; Wilson JE
    Am J Clin Pathol; 1977 May; 67(5):477-80. PubMed ID: 857645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The participation of phospholipids in the intrinsic pathway of the coagulantion process.
    Kunz F
    Klin Wochenschr; 1972 May; 50(10):528-30. PubMed ID: 5042540
    [No Abstract]   [Full Text] [Related]  

  • 17. [A lyophilized reagent for standardization of the activated partial thromboplastin time].
    Tarasova LN; Platonova GK; Starkova EV; Savinykh EIu
    Lab Delo; 1990; (6):29-32. PubMed ID: 1699033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid composition of seven APTT reagents in relation to heparin sensitivity.
    Kitchen S; Cartwright I; Woods TA; Jennings I; Preston FE
    Br J Haematol; 1999 Sep; 106(3):801-8. PubMed ID: 10468876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipid requirements of tissue thromboplastin in blood coagulation.
    Liu DT; McCoy LE
    Thromb Res; 1975 Jul; 7(1):213-221. PubMed ID: 1154339
    [No Abstract]   [Full Text] [Related]  

  • 20. PARTIAL THROMBOPLASTIN TIME TEST WITH KAOLIN. NORMAL RANGE AND MODIFICATIONS FOR THE DIAGNOSIS OF HAEMOPHILIA AND CHRISTMAS DISEASE.
    MATCHETT MO; INGRAM GI
    J Clin Pathol; 1965 Jul; 18(4):465-71. PubMed ID: 14318702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.